Zymride M 2 Tablet PR

The combination of these two agents offers complementary mechanisms of action, providing effective control of blood glucose levels in patients inadequately managed with diet and exercise alone. Zymride M 2 Tablet PR is designed for prolonged release, facilitating sustained therapeutic effects and improved patient compliance through reduced dosing frequency. It is recommended to be used alongside lifestyle modifications such as diet and exercise.

Caution is advised in patients with renal or hepatic impairment, and it is contraindicated in those with conditions predisposing to lactic acidosis. Regular monitoring of blood glucose, renal function, and potential adverse effects such as hypoglycemia and gastrointestinal disturbances is essential during therapy. This combination therapy should be prescribed and adjusted under medical supervision to optimize glycemic control and minimize risks.